DISACCHARIDE-2
Compound with spectra: 1 NMR
| SpectraBase Compound ID | CTkO4P1TTde |
|---|---|
| InChI | InChI=1S/C13H23NO17S2/c1-27-12-4(14-32(21,22)23)5(16)8(3(2-15)28-12)29-13-10(31-33(24,25)26)7(18)6(17)9(30-13)11(19)20/h3-10,12-18H,2H2,1H3,(H,19,20)(H,21,22,23)(H,24,25,26)/p-2/t3-,4-,5-,6+,7+,8-,9-,10-,12+,13-/m1/s1 |
| InChIKey | RHHFVAOPGUKJBX-OPWPDJBXSA-L |
| Mol Weight | 527.42 g/mol |
| Molecular Formula | C13H21NO17S2 |
| Exact Mass | 527.025091 g/mol |
| Enantiomer InChIKey | RHHFVAOPGUKJBX-IXXYCSRMSA-L |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
METHYL-2,6-DIACETAMIDO-2,6-DIDEOXY-4-O-[2-O-(ALPHA-L-FUCOPYRANOSYL)-BETA-D-GALACTOPYRANOSYL]-BETA-D-GLUCOPYRANOSIDE
GUALAMYCIN
METHYL-2-ACETAMIDO-2,6-DIDEOXY-6-FLUORO-4-O-[2-O-(ALPHA-L-FUCOPYRANOSYL)-BETA-D-GALACTOPYRANOSYL]-BETA-D-GLUCOPYRANOSIDE
->4)-BETA-D-GLCP-(1->3)-BETA)-D-MANP((S)-4-HC(CH3)COOH)-(1->4)-BETA-D-GLCPA-(1->4)-BETA-D-GALP-(1->
TRIDEUTEROMETHYL-3-O-(4-O-BETA-D-GALACTOPYRANOSYL-2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSYL)-BETA-D-GALACTOPYRANOSIDE
5-AMINOPENTYL-4-O-(2-ACETAMIDO-2-DEOXY-6-O-SULFO-BETA-D-GALACTOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDURONIC-ACID-SODIUM-SALT
4-TRIFLUOROMETHYLUMBELLIFERYL BETA-D-CELLOTRIOSIDE
Lacto-N-neotraose
2-N-ACETYL-BETA-GLUCOPYRANOSYL-(1B->4)-1A-METHYL-ALPHA-MANNOPYRANOSIDE
2-(TRIMETHYLSILYL)-ETHYL-ALPHA-D-FUCOPYRANOSYL-(1->3)-[ALPHA-D-FUCOPYRANOSYL-(1->4)]-2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Conformational analysis of synthetic heparin-like oligosaccharides containing α-L-idopyranosyluronic acid | Recueil des Travaux Chimiques des Pays-Bas | 1987 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.